Sun Fanglin, Chinese scientist who paved the way for new cancer drugs, dies aged 58
Renowned Chinese biologist Sun Fanglin, a pioneer in cancer research and cell aging, has passed away at the age of 58. His work on gene regulation and tumor resistance provided a theoretical foundation for modern anti-tumor drug development.
Why it matters
His contributions to translational medicine and immunology have significantly advanced the global understanding of cancer treatment and drug resistance.
Leading Chinese scientist Sun Fanglin, whose work on how cells age and form tumours helped pave the way for the development of new cancer treatments, has died aged 58.
Sun was director of the Advanced Institute of Translational Medicine at Tongji University in Shanghai and former dean of its School of Life Sciences and Technology.
He had been receiving treatment for an undisclosed illness and died on July 10, the institute said in an obituary posted on its website.
The noted biologist specialised in studying how the ageing process is affected by gene regulation and epigenetics – the way behaviour and the environment can alter the way genes work.
He served as chief scientist for several national research programmes, including the National Programme on Key Basic Research, according to Tongji University.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in